14-day Premium Trial Subscription Try For FreeTry Free
RSI low/high Values: [ 20 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ELDN
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Eledon Pharmaceuticals, Inc. stock price ended at $2.02 on Thursday, after gaining 2.54%.
(Updated on Apr 25, 2024)

Buy or Hold candidate since Apr 18, 2024 Gain 1.51% PDF

The Eledon Pharmaceuticals, Inc. stock price gained 2.54% on the last trading day (Thursday, 25th Apr 2024), rising from $1.97 to $2.02. During the last trading day the stock fluctuated 9.42% from a day low at $1.91 to a day high of $2.09. The price has been going up and down for this period, and there has been a 21.69% gain for the last 2 weeks. Volume fell on the last day by -33 thousand shares and in total, 67 thousand shares were bought and sold for approximately $136.07 thousand. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a very wide and weak rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 4.07% during the next 3 months and, with a 90% probability hold a price between $1.64 and $2.25 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ELDN Signals & Forecast

The Eledon Pharmaceuticals, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $1.94 and $1.80. A breakdown below any of these levels will issue sell signals. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, April 23, 2024, and so far it has fallen -6.48%. Further fall is indicated until a new bottom pivot has been found. Volume fell during the last trading day while the price increased. This causes a divergence and may be considered as an early warning, but it may also not.

Support, Risk & Stop-loss for Eledon Pharmaceuticals, Inc. stock

Eledon Pharmaceuticals, Inc. finds support from accumulated volume at $2.01 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move much during the day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.180 between high and low, or 9.42%. For the last week the stock has had daily average volatility of 13.80%.

Our recommended stop-loss: $1.91 (-5.28%) (This stock has high daily movements and this gives high risk. There is a sell signal from a pivot top found 2 days ago.)

Trading Expectations (ELDN) For The Upcoming Trading Day Of Friday 26th

For the upcoming trading day on Friday, 26th we expect Eledon Pharmaceuticals, Inc. to open at $2.01, and during the day (based on 14 day Average True Range), to move between $1.82 and $2.22, which gives a possible trading interval of +/-$0.196 (+/-9.73%) up or down from last closing price. If Eledon Pharmaceuticals, Inc. takes out the full calculated possible swing range there will be an estimated 19.45% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $2.01 (0.50%) than the resistance at $2.07 (2.48%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is Eledon Pharmaceuticals, Inc. stock A Buy?

Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Eledon Pharmaceuticals, Inc. stock to perform well in the short-term.

Current score: 2.228 Buy Candidate Unchanged

Predicted Opening Price for Eledon Pharmaceuticals, Inc. of Friday, April 26, 2024

Fair opening price April 26, 2024 Current price
$2.01 ( 0.660%) $2.02

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ELDN

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 2.19 8.25 %
R2 2.12 4.85 %
R1 2.08 2.74 %
Current price: 2.02
Support S1 1.94 -4.06 %
S2 1.90 -6.17 %
S3 1.83 -9.57 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 2.16 6.93 %
R2 2.13 5.45 %
R1 2.07 2.48 %
Current price 2.02
Support S1 2.01 -0.495%
S2 1.88 -6.93%
S3 1.86 -7.92%

FAQ

What is the symbol for Eledon Pharmaceuticals, Inc. Stock and on which exchange is it traded?
The symbol for Eledon Pharmaceuticals, Inc. is ELDN and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Eledon Pharmaceuticals, Inc. Stock?
Several short-term signals, along with a general good trend, are positive and we conclude that the current level may hold a buying opportunity as there is a fair chance for Eledon Pharmaceuticals, Inc. stock to perform well in the short-term.

How to buy Eledon Pharmaceuticals, Inc. Stock?
Eledon Pharmaceuticals, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Eledon Pharmaceuticals, Inc. Stock.

What's the current price of Eledon Pharmaceuticals, Inc. Stock?
As of the end of day on the Apr 25, 2024, the price of an Eledon Pharmaceuticals, Inc. (ELDN) share was $2.02.

What is the 52-week high and low for Eledon Pharmaceuticals, Inc. Stock?
The 52-week high for Eledon Pharmaceuticals, Inc. Stock is $2.95 and the 52-week low is $1.07.

What is the market capitalization of Eledon Pharmaceuticals, Inc. Stock?
As of the Apr 25, 2024, the market capitalization of Eledon Pharmaceuticals, Inc. is 48.88M.

When is the next earnings date for Eledon Pharmaceuticals, Inc.?
The upcoming earnings date for Eledon Pharmaceuticals, Inc. is May 09, 2024.
Click to get the best stock tips daily for free!

About Eledon Pharmaceuticals, Inc.

Eledon Pharmaceuticals. Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic lateral sclerosis (ALS), and requiring an organ or cell-based transplant. Its lead product candidate includes AT-1501, a humanized monoclonal antibody to target CD40 Ligand that is a molecule expressed on the surface of human immune system T cells, which is in Phase 2a clinical tri... ELDN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT